Literature DB >> 21220918

TGF-β1 induces podocyte injury through Smad3-ERK-NF-κB pathway and Fyn-dependent TRPC6 phosphorylation.

Lixia Yu1, Qiuxia Lin, Hua Liao, Jianhua Feng, Xiaohong Dong, Jianming Ye.   

Abstract

TGF-β1 plays an important role on podocyte injury and glomerular diseases, while the underlying molecular mechanisms are still elusive. Here, the potential role of the ion channel TRPC6 and the proximal signaling was explored in TGF-β1-treated mouse podocyte. Our results showed that TGF-β1 significantly increased podocyte apoptosis and induced obvious disorganization of actin filaments in a time-dependent pattern. In TGF-β1-treated podocyte, TRPC6 protein, especially the phosphorylated TRPC6, and the cytosolic free Ca(2+) level upregulated, which was evidently inhibited by the specific knockdown of TRPC6. TRPC6 knockdown also alleviated TGF-β1-induced podocyte apoptosis. Moreover, the Src kinase Fyn increased obviously in TGF-β1-treated podocyte, displaying increment of the active form pY418 and reduction of the inactive form pY530. Immunoprecipitation assay revealed that Fyn interacts with TRPC6 in podocyte. Notably, Fyn knockdown blocked TRPC6 phosphorylation and intracellular Ca(2+) increment following TGF-β1 stimulation, but not affect the expression of TRPC6 protein. In addition, Western blot showed that TGF-β1 induced significant activation of p-Smad3, p-ERK and RelA/p65. Importantly, obvious translocation of ERK and RelA/p65 to nuclei was observed in TGF-β1-treated podocyte, which was reduced by ERK inhibitor U0126. Both U0126 and NF-κB inhibitor PDTC obviously inhibited the increment of TRPC6 protein and the flux of cytosolic free Ca(2+) induced by TGF-β1. Together, we provide evidences that TGF-β1 induces podocyte damage by upregulating TRPC6 protein most possibly through Smad3-ERK-NF-κB pathway, in which Fyn-dependent tyrosine phosphorylation of TRPC6 might exert a crucial role on the activation of its channel function.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220918     DOI: 10.1159/000323996

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  12 in total

1.  Deletion of diacylglycerol-responsive TRPC genes attenuates diabetic nephropathy by inhibiting activation of the TGFβ1 signaling pathway.

Authors:  Benju Liu; Xiju He; Shoutian Li; Benke Xu; Lutz Birnbaumer; Yanhong Liao
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 2.  Role of TRPC6 in Progression of Diabetic Kidney Disease.

Authors:  Alexander Staruschenko; Denisha Spires; Oleg Palygin
Journal:  Curr Hypertens Rep       Date:  2019-05-21       Impact factor: 5.369

Review 3.  Ion channels in cancer: future perspectives and clinical potential.

Authors:  Florian Lang; Christos Stournaras
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

4.  Transforming Growth Factor β1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis.

Authors:  Ranjan Das; Shanhua Xu; Tuyet Thi Nguyen; Xianglan Quan; Seong-Kyung Choi; Soo-Jin Kim; Eun Young Lee; Seung-Kuy Cha; Kyu-Sang Park
Journal:  J Biol Chem       Date:  2015-11-12       Impact factor: 5.157

5.  Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic Nephropathy.

Authors:  Keiichiro Matoba; Daiji Kawanami; Yosuke Nagai; Yusuke Takeda; Tomoyo Akamine; Sho Ishizawa; Yasushi Kanazawa; Tamotsu Yokota; Kazunori Utsunomiya
Journal:  Int J Mol Sci       Date:  2017-08-18       Impact factor: 5.923

6.  Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury.

Authors:  Yizhen Sang; Kenji Tsuji; Akiko Inoue-Torii; Kazuhiko Fukushima; Shinji Kitamura; Jun Wada
Journal:  Int J Mol Sci       Date:  2020-06-08       Impact factor: 5.923

7.  Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3-kinase-protein kinase B pathway in diabetic rats.

Authors:  Wei-Jian Ni; Hong Zhou; Hai-Hua Ding; Li-Qin Tang
Journal:  J Diabetes Investig       Date:  2019-07-23       Impact factor: 4.232

8.  Integrated UPLC-MS and Network Pharmacology Approach to Explore the Active Components and the Potential Mechanism of Yiqi Huoxue Decoction for Treating Nephrotic Syndrome.

Authors:  Dan Feng; Xiang-Ri Li; Zhao-Yi Wang; Nian-Nian Gu; Shuang-Xi Zhang; Chao-Feng Li; Yang Chen; Zhi-Qiang Ma; Rui-Chao Lin; Hong-Gui Zhang; Chongjun Zhao
Journal:  Front Pharmacol       Date:  2022-02-24       Impact factor: 5.810

Review 9.  Bioelectric Dysregulation in Cancer Initiation, Promotion, and Progression.

Authors:  Maulee Sheth; Leyla Esfandiari
Journal:  Front Oncol       Date:  2022-03-14       Impact factor: 6.244

Review 10.  Fyn Kinase: A Potential Therapeutic Target in Acute Kidney Injury.

Authors:  Md Jamal Uddin; Debra Dorotea; Eun Seon Pak; Hunjoo Ha
Journal:  Biomol Ther (Seoul)       Date:  2020-05-01       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.